A
Ascendis Pharma is a biopharmaceutical company developing novel therapies utilizing its proprietary TransCon technology platform. The company focuses on advancing product candidates in Endocrinology Rare Disease and Oncology through clinical development. This technology aims to improve treatment safety, efficacy, tolerability, and convenience for patients with unmet medical needs.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Ascendis Pharma is a biopharmaceutical company developing novel therapies utilizing its proprietary TransCon technology platform. The company focuses on advancing product candidates in Endocrinology Rare Disease and Oncology through clinical development. This technology aims to improve treatment safety, efficacy, tolerability, and convenience for patients with unmet medical needs.